tiprankstipranks

Biologics Profile - Seeking Alpha Blogger

25 Followers
tipranks
Biologics

Biologics
Seeking Alpha

Financial Blogger
#3,132 out of 17,524 Financial Bloggers
#6,161 out of 29,907 experts

Success Rate

41%
116 out of 281 ratings made a profit

Average Return

+5.50%
Average return per rating
Time Frame
1 Year
Compare to
No Benchmark
Copying Biologics's trades since 2019 and holding each position for 1 Year would result in 41.28% of your transactions generating a profit, with an average return of 5.5% per rating.

Stock Rating Distribution

298Ratings
94.97% Bullish
4.36% Neutral
0.67% Bearish
Distribution of Biologics's ratings

Additional Information

Main Sector:General
Geo Coverage:
United States

Best Rating

Stock:
Novavax
(NVAX)
Rating:Buy
Date:Sep 03, 2019 - Sep 03, 2020
Return:+800.00%
The most profitable rating made by Biologics

Biologics's Stock Coverage

Company Name
Date
Position
No. of Ratings
Success Rate
Avg Return
Seelos Therapeutics
Jul 01, 2019
Neutral
1Ratings
0.00%
CVS Health
Sep 08, 2019
Bullish
1Ratings
0%
-1.30%
Bristol-Myers Squibb
Sep 18, 2019
Bullish
1Ratings
100%
+22.60%
Elevance Health
Sep 25, 2019
Bullish
1Ratings
100%
+6.00%
Purple Biotech
Oct 17, 2019
Bullish
6Ratings
20%
-26.18%
Merck & Company
Nov 04, 2019
Bullish
1Ratings
0%
-0.90%
Carisma Therapeutics
Feb 04, 2020
Bullish
1Ratings
100%
+139.50%
Atossa Therapeutics
Jun 02, 2020
Bullish
1Ratings
100%
+56.30%
Teva Pharmaceutical
Jun 18, 2020
Bullish
2Ratings
0%
-24.75%
Amarin
Aug 12, 2020
Bullish
5Ratings
0%
-44.10%
List of latest recommendations made by Biologics. Click to expand and see Biologics's performance on a particular stock
Disclaimer: TipRanks collects ratings of bloggers by scanning publicly available reports on financial websites and by receiving reports directly from the bloggers or from our users. The information displayed might not be accurate or up to date. The displayed ratings are made entirely at the sole discretion of the bloggers. TipRanks holds no liability over the bloggers information or opinions expressed on the site.